0143-9170 : Starjemza 90 mg/ml Subcutaneous Injection
| NDC: | 0143-9170 |
| Labeler: | Hikma Pharmaceuticals USA Inc. |
| Product Type: | Human Prescription Drug |
| Drug Name: | Starjemza |
| Dosage Form: | Subcutaneous Injection |
| Application #: | BLA761419 |
| Rev. Date: |
NDC Package Codes:
- 0143-9170-01: 1 ML IN 1 SYRINGE (0143‑9170‑01)
Active Ingredients:
- Ustekinumab
Dosage Strength:
- 90 mg/mL
Pharmaceutical Classes:
- Interleukin-12 Antagonist [EPC]
- Interleukin-12 Antagonists [MoA]
- Interleukin-23 Antagonist [EPC]
- Interleukin-23 Antagonists [MoA]
Related Products:
Based on records with the same trade name.- 0143-9168 Starjemza 45 mg/.5ml Subcutaneous Injection by Hikma Pharmaceuticals USA Inc.
- 0143-9169 Starjemza 45 mg/.5ml Subcutaneous Injection by Hikma Pharmaceuticals USA Inc.
- 0143-9171 Starjemza 130 mg/26ml Intravenous Injection by Hikma Pharmaceuticals USA Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 0143-9169Next: 0143-9171 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.